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Abstract
Background: Predicting antibiotic resistance before it emerges at clinical settings constitutes a
novel approach for preventing and fighting resistance of bacterial pathogens. To analyse the
possibility that novel plasmid-encoded quinolone resistance determinants (Qnr) can emerge and
disseminate among bacterial pathogens, we searched the presence of those elements in nearly 1000
bacterial genomes and metagenomes.
Results: We have found a number of novel potential qnr genes in the chromosomes of aquatic
bacteria and in metagenomes from marine organisms. Functional studies of the Stenotrophomonas
maltophilia Smqnr gene show that plasmid-encoded SmQnr confers quinolone resistance upon its
expression in a heterologous host.
Conclusion: Altogether, the data presented in our work support the notion that predictive
studies on antibiotic resistance are feasible, using currently available information on bacterial
genomes and with the aid of bioinformatic and functional tools. Our results confirm that aquatic
bacteria can be the origin of plasmid-encoded Qnr, and highlight the potential role of S. maltophilia
as a source of novel Qnr determinants.
Background
Quinolones are synthetic antibiotics; therefore, it was
thought that the existence of transferable quinolone
resistance genes in nature would be unlikely. Resistance
mechanisms for these drugs were expected to be only
chromosomally encoded. It was believed that only muta-
tions in the quinolone targets (DNA gyrase or topoi-
somerase IV) or mutations that led to a permeability
decrease and/or overproduction of multidrug resistance
(MDR) efflux pumps would result in resistance to these
antibiotics [1,2].
It was thus assumed that resistance to quinolones could
not spread as the consequence of horizontal gene transfer
Published: 16 September 2008
BMC Microbiology 2008, 8:148 doi:10.1186/1471-2180-8-148
Received: 12 March 2008
Accepted: 16 September 2008
This article is available from: http://www.biomedcentral.com/1471-2180/8/148
© 2008 Sánchez et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 14
(page number not for citation purposes)
BMC Microbiology 2008, 8:148 http://www.biomedcentral.com/1471-2180/8/148(HGT). Later on, the acquisition of quinolone resistance
due to HGT was proposed as a possibility based on in vitro
experiments [3]. This was later confirmed in 1998, with
the description of a plasmid-encoded quinolone resist-
ance determinant, that was named Qnr, in clinical isolates
[4]. More recently two other transferable quinolone resist-
ance determinants have been described, the bifunctional
aminoglycoside/quinolones inactivating aminoglycoside
acetyltransferase AAC(6')-Ib-cr [5,6] and the quinolone
efflux determinant, QepA [7,8].
Since the discovery of Qnr, the presence of different qnr
families (A, B, S) in resistance plasmids [9] has been
found worldwide in different bacterial pathogens [10-15].
More recently, plasmid-encoded Qnr determinants have
also been described in environmental isolates of Aerom-
onas spp. [16]. The presence of Qnr genes in chromo-
somes has also been shown, including QnrA in Shewanella
algae, which is likely the origin of plasmid-encoded QnrA
determinants [17], and different members of the Qnr fam-
ily from Vibrionaceae species [18,19].
The Qnr proteins belong to the pentapeptide repeat pro-
tein (PRP) family, which is defined by the presence of rep-
etitions in tandem of the pattern (A/C/S/T/V)(D/N)(L/
F)(S/T/R)(G/R) [20-22,17]. A characteristic feature of the
Qnr proteins is that they are formed by two domains of
pentapeptide repeats separated by a single glycine. This
structure matches a motif of unknown function named
Cluster of Orthologous Group of Proteins (COG) 1357
http://www.ncbi.nlm.nih.gov/COG/. Even though mem-
bers of the PRP family have been identified both in
prokaryotes and eukaryotes [22], qnr genes presenting the
above described COG1357 motif have a much narrower
distribution, mainly in plasmids and in the chromosomes
of some bacterial species. The amino acid identity among
different Qnr proteins families rates between 39–60%
[23].
Some studies have demonstrated that Qnr protects both
gyrase and topoisomerase IV from the activity of quinolo-
nes [15,24-26]. Other members of the PRP family, that
may play a similar role include McbG, which protects
microcin B17-producing bacteria from the activity of this
DNA replication inhibitor [27] and MfpA [28], a protein
that most likely binds GyrA [22] and provides low-level
quinolone resistance to Mycobacterium tuberculosis.
Although qnr-like elements that contribute to intrinsic
quinolone resistance have been described in the chromo-
some of Enterococcus faecalis [24] and more recently in
other Gram-positive bacteria [29], their homology with
qnr genes from Gram-negative bacteria is low (around
25%), so that this family of resistance elements has not
been included in our analysis.
It is important to note that plasmid-encoded quinolone
resistance is more prevalent than expected considering the
date of the first isolation, which suggests that these plas-
mids have been circulating for some time before they were
first described [30]. This highlights the need to implement
methods to predict resistance before it is recognized
within clinical settings.
A methodology for predicting the possibility of emergence
of a new mechanism of resistance before it appears in bac-
terial pathogens has been recently proposed [31]. The
availability of sequenced genomes allows this type of
analysis. This information was used to search for the pres-
ence of Qnr determinants in available sequenced bacterial
genomes and metagenomes. A putative qnr gene present
in the chromosome of the opportunistic pathogen Steno-
trophomonas maltophilia was chosen to perform functional
analyses. S. maltophilia is a nosocomial pathogen intrinsi-
cally resistant to several antimicrobials [32] due to the
activity of antibiotic-inactivating enzymes [33-36] and
MDR efflux pumps [37-43].
The possibility that chromosomally-encoded S. mal-
tophilia qnr gene (hereafter named as Smqnr) could be
functional in a heterologous host has been explored. As
the result of our work, we have described new qnr genes in
the chromosomes of sequenced bacterial genomes and
have found that the Smqnr gene from S. maltophilia
renders a low-level quinolone resistance phenotype upon
its expression in Escherichia coli. This study demonstrates
the feasibility of utilizing currently available databases
along with bioinformatics and functional tools as an
approach for predicting resistance before it emerges in
human pathogens.
Methods
Bioinformatic tools and nomenclature of predicted Qnr 
proteins
Multiple protein sequence alignments were carried out
with the program ClustalW2 http://www.ebi.ac.uk/Tools/
clustalw2/index.html[56]. Similarity search was per-
formed with the program BLAST (NCBI) http://
www.ncbi.nlm.nih.gov/blast/Blast.cgi[57] and genomic-
Blast http://www.ncbi.nlm.nih.gov/sutils/
genom_table.cgi. Identification of conserved motifs [58]
([59] was done by using Conserved Domain Database
and Search Service at http://www.ncbi.nlm.nih.gov/Struc
ture/cdd/cdd.shtml. The Qnr proteins alignments and
homology trees were obtained using CLUSTALW2 and
Jalview alignment editor with default parameters [60].
Homology tree was calculated using the method "Average
distance using percentage of identity" http://
www.ebi.ac.uk/Tools/clustalw2/index.html.
The predicted Qnr proteins were named following the
rules proposed in [61].Page 2 of 14
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The bacterial strains and plasmids used are shown in
Table 1. The strains were grown in Luria-Bertani (LB)
broth [62] at 37°C unless otherwise specified.
Susceptibility antibiotic assays
The susceptibility assays for the different antibiotics were
performed in Mueller Hinton broth (Pronadisa) plus Iso-
propyl-thio-ß-D-galactopyranoside 0.5 mM, using the
twofold dilution method in 96-well microtiter plates. The
results were recorded after 48 h of incubation at 37°C. To
ensure that the observed changes were consistent, all Min-
imal Inhibitory Concentrations (MICs) were determined
in three independent assays, using different bacterial cul-
tures on different days. In all cases, a control strain con-
taining the plasmid pGEM-T without any insert was
included in MICs determinations. In most cases, there
were not inter-assay differences in the MIC values. In a few
cases, there were one-dilution differences. For the latter,
the assay was repeated one more time to further assure
assay reliability.
The quinolones used were ciprofloxacin, enoxacin,
garenoxacin, grepafloxacin, levofloxacin, moxifloxacin,
nalidixic acid, norfloxacin, trovafloxacin and sparfloxacin.
DNA manipulations
The genomic DNA was extracted using the GNOME® DNA
Kit (Q-BIOgene). The PCR Master Mix (Promega) was
used to amplify full-length Smqnr genes from the different
S. maltophilia strains without their promoter sequences.
The reaction contained 100 ng of genomic DNA of each S.
maltophilia isolate as template, and 1 μM of two different
sets of specific Smqnr-primers, QnrM+ (5'-CTTGGCAT-
GGAATCCCTGAT-3')/QnrM-(5'-TGATGCCTACGGCAC-
CAC-3') and QnrMR55+ (5'-CATGGCATGGAATCCCCGA
T-3')/QnrMR55-(5'-TGATGTCTACGGCACCAC-3'). We
used two sets of primers because the regions around qnr
are slightly different in the sequenced S. maltophilia strains
K279a and R551-3. The reactions had one denaturation
step at 94°C for 5 minutes, followed by 35 amplification
cycles: 94°C for 30 seconds, 61°C for 45 seconds for
annealing, and 72°C for 1 minute for elongation, with a
final extension step of 72°C for 5 minutes. The PCR prod-
ucts (660 bp) obtained from the different S. maltophilia
strains (Table 1) were electrophoresed in 1% agarose gels
with TAE, purified from the gel with GFX™ PCR DNA and
Gel Band Purification Kit (GE Healthcare) and cloned in
pGEM-T plasmid (Promega) generating the correspond-
ing recombinant plasmids (Table 1). The transformation
of E. coli KZM120 was made as described [63]. We chose
this particular E. coli strain because it lacks the major E.
coli MDR pump and it has been shown previously that the
utilization of MDR-defective strains facilitates the charac-
terization of low-level mechanisms of resistance [39]. The
transformants were selected in LB agar with 100 μg/ml
carbenicillin. The recombinant plasmids were purified
using Wizard® Plus SV Miniprep Kit (Promega) and the
insert of each plasmid was sequenced using the universal
primers M13 forward and M13 reverse by Secugen S.L.
http://www.secugen.es/ to confirm the identity of the
sequence and establish the orientation of the qnr gene.
The sequences of the different Smqnr genes have been
deposited at GenBank with numbers from EU681371 to
EU681385. Only those plasmids containing the Smqnr
gene in the right orientation to allow expression from the
pGEM-T lac promoter were used in the functional assays.
Identification of Smqnr in different S. maltophilia isolates
The potential presence of Smqnr in both clinical and envi-
ronmental S. maltophilia strains was evaluated by PCR
using the primers qnrI1 (5'-AGAAAGTGGTCGACCAG-
CAG-3')/qnrI2 (5'-GCAGGTTCGACTTCTTGATG-3') and
qnrI3 (5'-CAACGCCAGCTTCATGAACC-3')/qnrI4 (5'-
AGTTGGCGCTGTTCCAGTCG-3'), which amplify 312 bp
and 220 bp fragments of two internal regions in the
Smqnr gene of S. maltophilia respectively.
The PCR was made as described above, with the following
program, one denaturation cycle at 94°C for 5 minutes,
followed by 35 amplification cycles: 94°C for 30 seconds,
55°C for 45 seconds for annealing, and 72°C for 30 sec-
onds for polymerization, with a final extension of 72°C
for 5 minutes. The PCR products were analyzed in 1% aga-
rose gels with TAE.
Expression and identification of the SmQnr protein
The amount of SmQnr protein was estimated by SDS-
PAGE [63] and Coomassie blue staining, using cell
extracts from bacteria grown in LB at 37°C overnight. The
amount of proteins loaded in each lane was normalized to
around 4 × 107 cells. In all cases, the global amount of
proteins was equal in all lanes of a given gel as can be seen
after staining. This serves as a supplementary loading con-
trol [64].
To ensure that the protein with the predicted molecular
size was indeed SmQnr, the corresponding band was
excised and identified, as described [65,39] by Peptide
Mass Fingerprinting using MS-MALDI TOF (Proteored:
http://www.proteored.org/).
Ethical considerations
This investigation did not require ethical clearance.
Results and Discussion
The identification in environmental microorganisms of
putative antibiotic resistance elements [44] that might
transfer in the near future to pathogenic bacteria is an
important topic that we are just beginning to address [31].Page 3 of 14
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tional tools can give information to predict resistance
before it emerges. Following this concept, we have
explored the presence of putative qnr genes in available
databases of bacterial genome sequences, because the
genetic context of plasmidic qnr genes supports the idea
that they have been acquired by HGT. For instance, the
plasmid-encoded qnrA gene has been found in a sul1-type
integron near an ISCR1 element [21,45,25]. A similar
structure was found in qnrB2 [46], and qnrS is adjacent to
a Tn3 transposon structure [10,11]. In contrast, it has
been reported that chromosomal qnrA, in Shewanella algae
[17] and several qnr-like genes identified within the Vibri-
onacea family [18] are not linked to these mobile genetic
elements.
This suggests that chromosomally-encoded qnr genes
have not been acquired recently by HGT because of recent
antibiotic selective pressure and that yet unidentified
chromosomally-encoded qnr genes could be a source of
new transferable quinolone resistance genes.
Bioinformatic search of putative qnr genes
To address the presence of putative qnr genes in the chro-
mosomes of bacteria that could serve as reservoirs of this
family of quinolone resistance determinants, a bioinfor-
matic iterative search by sequence homology to several
alleles of QnrA, QnrB and QnrS was conducted against
genomic or Whole Genome Shotgun Sequence (WGS)
databases at the NCBI home page http://
www.ncbi.nlm.nih.gov/. Most of the putative qnr genes
found in this search have been previously annotated as
hypothetical proteins containing the COG1357 motif. As
shown in Figure 1, chromosomally-encoded Qnr proteins
present a large degree of homology.
Putative qnr genes were found in 22 out of the 960
genomes tested. The species containing putative qnr genes
belong to eight different genera (Figure 2). Most of them
inhabit an aquatic environment (in some instances the
deep sea) suggesting that plasmidic qnr may have been
originated from aquatic bacteria [17,19,18].
Since the large majority of bacterial species have not been
cultured so far, metagenomic studies allow a more power-
ful search of relevant genes in different environments by
means of non-culture based methodologies. Thus, besides
analysing sequenced genomes, available metagenomic
sequence databases http://www.ebi.ac.uk/fasta33/
wgs.html were also searched for the presence of qnr genes.
Our study showed that the metagenomes from sea-water
[47] contain genes homologous to qnr (hereafter named
as Mtgqnr), further supporting the notion that qnr genes
are originated from aquatic microorganisms. One of the
qnr sequences found in this metagenomic search was
highly homologous to plasmid-encoded QnrB [15] pro-
teins (Figure 3). It has been shown that S. algae is likely
the origin of plasmid-encoded qnrA genes [17]. Our anal-
yses, strongly suggest that plasmid-encoded qnrB has also
originated from a currently unknown, marine microor-
ganism.
The regions surrounding the chromosomal qnr genes
found in our bioinformatics analysis were analysed to
ascertain whether, based in the level of sinteny, the origin
of these qnr determinants is likely monophyletic or
polyphyletic. As shown in Figure 2, and in Additional file
1, the regions are very similar for some of the analysed
species belonging to the same genus, although clear differ-
ences are also observed for other species.
For instance, the structure surrounding qnr in Vibrio is very
similar for three species, whereas the structure in five
other species and in Photobacterium profundum is different.
The high level of observed sinteny in these regions, sug-
gests that qnr was acquired by Vibrio parahaemolyticus,
Vibrio alginolyticus and Vibrio harveyi before their diver-
gence, and was acquired by the other Vibrionaceae after
their divergence. This idea fits well with the relationship
of Vibrio Qnr proteins (Figure 4).
Sequence data were inspected for the presence of elements
potentially involved in the transfer of qnr genes. As shown
in Figure 2, putative transposases or integrases were found
in the regions surrounding the qnr determinants in some
Shewanella species, and one putative recombinase was
found as well in Moritella sp. Whether those elements are
remnant of former gene transfer events or constitute a risk
for the transference of those qnr genes through HGT to a
new host, remains to be established.
In any case, the analyses of available sequences of bacte-
rial genomes suggest that qnr genes are ancient elements
in the bacterial chromosomes of a specific subset of bacte-
rial species. Noteworthy, those genes are frequently
flanked by genes coding for putative efflux pumps (Figure
2), a situation that suggests that Qnr may have functional
roles in detoxification processes in water-dwelling bacte-
ria. Although this linkage has not been so far observed for
plasmid-encoded qnr genes, the cooperation of two differ-
ent mechanisms of resistance might be an important ele-
ment in current resistance to quinolones.
A putative qnr gene is present in the chromosome of S. 
maltophilia
Once the bioinformatic analysis was made, we focused
our efforts in the study of the organism with highest clin-
ical relevance. Among the organisms carrying putativePage 4 of 14
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Homology of predicted new chromosomally-encoded Qnr proteinsFigure 1
Homology of predicted new chromosomally-encoded Qnr proteins. The Figure shows the alignment of chromosoma-
lly-encoded putative Qnr proteins from the analysis of around 1000 genomes and metagenomes. The figure includes one mem-
ber of each plasmidic Qnr protein family (highlighted in red), so that the similarities are clearer. The putative Qnr protein from 
the sea metagenome is also included (MtgQnr). As shown in the Figure, conservation is high along the proteins, although the 
similarities are lower at their N-terminus. The automated annotation of Swoqnr presents two stop codons. Since we ignore 
whether this is a sequence mistake or Swoqnr is a pseudogene, a manual translation of its nucleotide sequence was performed 
for this alignment. Stop codons are represented with an X. Accession numbers of the proteins used for the alignment are: 
AhQnr (YP_854820.1), AsQnr (YP_001143795.1), MsQnr (ZP_01897167.1), QnrA1 (ACA43024), QnrB1 (ABG82188), 
QnrS1 (ABU86826), SbeQnr (ZP_02157732.1), SfrQnr (YP_750786.1), SliQnr (ABO22341.1), SmQnr (ZP_01643096.1), 
SpaQnr (ABV89003.1), SprQnr (YP_001478290.1), SseQnr (ABV35251.1), SwoQnr (ZP_01539189.1), PpQnr (CAG21998.1), 
PsQnr (EAS39797.1), ValQnr (ZP_01261394.1), VanQnr (ZP_01234687.1), VfQnr (ZP_02136549.1), VhQnr (ZP_01985396.1), 
VpQnr (ZP_01990287.1), VshQnr (ZP_01866232.1), VspQnr (ZP_00989608.1), VvQnr (AAO07889.1) and MtgQnr 
(AACY020347520).
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Predicted qnr genes in genome databasesFigure 2
Predicted qnr genes in genome databases. The structure of the regions surrounding predicted qnr genes (in red) is 
shown. Elements that might contribute to transfer of those genes are highlighted in black. The presence of putative MDR sys-
tems is also highlighted. WGS (whole genome shotgun), CG (Complete genome), Chr (Chromosome). Only those putative qnr 
determinants showing more than 45% identity with known plasmid-encoded QnrA or QnrB determinants were included in the 
analysis. The abbreviations used in the Figure are shown in Additional file 1.
BMC Microbiology 2008, 8:148 http://www.biomedcentral.com/1471-2180/8/148uncharacterized qnr genes we chose S. maltophilia, which
is an intrinsically resistant opportunistic pathogen
responsible for 4.3% of Gram-negative infections among
intensive care units patients in the USA [48].
Noteworthy, in S. maltophilia resistance to fluoroquinolo-
nes (particularly to less active ones, such as norfloxacin) is
not always accompanied by high level resistance to nalid-
ixic acid, which is the usual and classical association in
Enterobacteria. Interestingly, resistance to fluoroquinolo-
nes and susceptibility to nalidixic acid in S. maltophilia
resemble the phenotype recently observed by Cano ME et
al (unpublished results) in some Enterobacteriaceae con-
taining qnr genes. A putative qnr gene (Smqnr) was identi-
fied in the two available full-genome sequences of S.
maltophilia: the clinical isolate K279a http://
www.sanger.ac.uk/Projects/S_maltophilia/[49], and the
environmental strain R551-3, http://genome.jgi-psf.org/
draft_microbes/stema/stema.home.html. As shown in
Figure 2, the genomic structure around Smqnr was the
same in both strains, in spite their different (clinical and
environmental) source of isolation.
This high degree of sinteny, together with the lack of ele-
ments involved in HGT near Smqnr suggests that this gene
has an ancient origin in S. maltophilia. Further confirma-
tion of this likely monophyletic origin has been obtained
from the analyses of the Smqnr sequence from different S.
maltophilia isolates in this study. The predicted translation
of Smqnr sequence is a 219 amino acid protein (Figure 5),
containing tandem repetitions of the pattern (A/C/S/T/
V)(D/N)(L/F)(S/T/R)(G/R) typical of the pentapeptide
family [20,18,22], with two domains of pentapeptide
repeats separated by a single glycine, that corresponds to
a COG1357 motif.
Prevalence of the Smqnr gene in Stenotrophomonas 
maltophilia strains
Since Smqnr might be involved in quinolone resistance,
we wanted to ascertain the prevalence of this gene in S.
maltophilia populations. To that goal, and since the
sequences of the qnr genes of the strains K279a and R551-
3 were slightly different, two pairs of oligonucleotides
QnrM+/- and QnrMR55+/- were designed to amplify
Smqnr genes from different S. maltophilia strains. The set
of analysed strains comprised both clinical and environ-
mental S. maltophilia isolates (Table 1).
The SmQnr sequences from the different strains display a
high amino acid identity, ranking from 94 to 100% (Fig-
ure 5). However the amino acid identity of the SmQnr
protein encoded in the chromosome of the sequenced S.
maltophilia strain K279a, is low compared with other
known Qnr proteins, sharing 38%, 59%, 38% and 41%
with QnrA1 (AY070235), QnrB2 (DQ351241), QnrS2
(AB187515) and VvQnr (DQ889870) respectively. For
this reason we consider that Smqnr represents a possible
new subtype of qnr genes. Clustal analysis (Figure 4) indi-
cates that the SmQnr protein clusters with plasmidic QnrB
proteins, although forms a separate branch. Therefore, our
results suggest that SmQnr is the first characterized chro-
mosomally encoded QnrB-like protein.
We were unable to amplify the full qnr gene from the iso-
lates E729, F227, E301, F861 and e-p5. Since qnr
sequences where slightly different in K279a and R551-3,
as well as in the isolates analysed in the present study, two
new pairs of oligonucleotides (qnrI1/qnrI2 and qnrI3/
qnrI4) were used to amplify an internal conserved region
of Smqnr. Positive amplification was obtained in all cases
(not shown) indicating that all S. maltophilia isolates con-
tained the qnr gene.
Alignment of the plasmid-encoded protein QnrB with a putative Qnr protein encoded in a marine metagenomeFigure 3
Alignment of the plasmid-encoded protein QnrB with a putative Qnr protein encoded in a marine metagen-
ome. The percentage of identity between both proteins was 94.9%, with a homology of 99.5%. Top QnrB5, bottom Qnr pro-
tein from a marine metagenome (MtgQnr). Two dots indicate identical amino acids, one dot homologous amino acids.Page 7 of 14
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BMC Microbiology 2008, 8:148 http://www.biomedcentral.com/1471-2180/8/148Functional analysis of SmQnr as a quinolone resistance 
determinant in a heterologous host
To ascertain whether SmQnr might contribute to qui-
nolone resistance in a heterologous host, the different
alleles of the qnr gene obtained from different S. mal-
tophilia strains were cloned into the plasmid pGEM-T.
Corresponding recombinant plasmids, containing the
Smqnr gene, were expressed in E. coli, and the quinolone
susceptibility of strains expressing SmQnr was compared
to that of the isogenic E. coli strain. We found that in trans
expression of SmQnr from different recombinant plasmid
results in a 2 to 32-fols decrease in the quinolone suscep-
tibility of E. coli (Table 2).
Noteworthy, different recombinant strains presented
slight, but consistent, differences in their susceptibility to
several quinolones (Table 2). It has been previously stated
that transconjugants of plasmids containing the qnr gene
present disparate levels of quinolone resistance, likely due
to different levels of expression of the Qnr protein in the
Clustal analysis of Qnr proteinsFigure 4
Clustal analysis of Qnr proteins. Characterized and predicted Qnr proteins were clustered. The tree was calculated using 
the average percentage of identity. Other two members of the pentapeptide repeat family with proven resistance to fluoroqui-
nolones, MfpA from Mycobacterium tuberculosis and McbG from Escherichia coli, were included in the analysis, but are not shown 
because they plotted out of the Qnr tree. Chromosomally-encoded Qnr proteins are highlighted in bold. The position of the 
SmQnr protein from S. maltophilia as a member of the QnrB cluster is highlighted with a square. Novel Qnr proteins are 
named according to the species where they are originated: AhQnr (Aeromonas hydrophila), AsQnr (Aeromonas salmonicida), 
MsQnr (Moritella sp), SprQnr (Serratia proteamaculans), SbeQnr (Shewanella benthica), SfrQnr (Shewanella frigidimarina), SliQnr 
(Shewanella loihica), SpaQnr (Shewanella pealeana), SseQnr (Shewanella sediminis), SwoQnr (Shewanella woodyi), SmQnr (Stenotro-
phomonas maltophilia), PsQnr (Psychromonas), ValQnr (Vibrio alginolyticus), VanQnr (Vibrio angustum), VfQnr (Vibrio fischeri), 
VhQnr (Vibrio harveyi), VshQnr (Vibrio shilonii), VspQnr (Vibrio splendidus), VvQnr (Vibrio vulnificus).Page 8 of 14
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BMC Microbiology 2008, 8:148 http://www.biomedcentral.com/1471-2180/8/148Alignment of deduced amino acid sequences of different SmQnr proteinsFigure 5
Alignment of deduced amino acid sequences of different SmQnr proteins. The amino acids that changed in the dif-
ferent SmQnr alleles are highlighted in a grey square. The glycine residue (G) separating the two domains of pentapetide 
repeats, is marked with a box.
different transconjugants [50]. To ascertain whether this
could be the situation with the different SmQnr-express-
ing plasmids, the expression of the SmQnr protein was
estimated in the different E. coli transformants. As shown
in Figure 6A, transformants containing either pBS3.25 or
pBS3.13 expressed higher levels of SmQnr than the other
transformants.
During our work, we detected that some Qnr-expressing
plasmids were lost after subculturing even in the presence
of ampicillin, although they could be maintained in the
presence of carbenicillin. Plasmid loss after the bacteria
has degraded the selective antibiotic is an indication of
physiological burden [51]. Our results suggest that high-
level expression of SmQnr is likely harmful for E. coli. It is
possible that, as described for other systems [52], a fast
adaptation between the host cell and the plasmid
occurred that results in reduced levels of SmQnr and that
this allowed some of the clones to overcome the putative
SmQnr toxicity. To address this possibility, E. coli
KZM120 was retransformed with the plasmids pBS3.8,
pBS3.25 and pBS3.13. Two different clones from each
retransformation were chosen and their susceptibility to
quinolones tested. As shown in Table 3, an overall reduc-
tion in MICs as well as in the level of SmQnr expression
(Figure 6B) was observed for the new transformants con-
taining the plasmids pBS3.8, pBS3.25 and pBS3.13. How-
ever, the phenotype of reduced susceptibility to
quinolones was maintained. Increased resistance due to
higher expression of antibiotic resistance genes has been
described mainly associated with plasmidic beta-lactama-
ses [53-55]. Our results together with already published
data indicate that gene-dosage might be relevant for qnr-
mediated quinolone resistance.
Conclusion
By using a combination of bioinformatics and functional
tools, we found a number of novel putative qnr genes in
the chromosomes of aquatic bacteria and in metagen-
omes from marine organisms. This further supports the
notion that the origins of qnr determinants are in water-
dwelling bacteria. It has been recently shown that Aerom-
onas spp. obtained from water samples contain plasmid-
encoded qnr genes [16]. These results have been inter-
preted as a consequence of the presence of quinolones in
rivers that drive the evolution of aquatic bacteria towards
quinolone resistance. This explanation is likely true for
plasmid-encoded qnr genes. However, the presence of qnr-Page 9 of 14
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Strain or plasmid Description Reference or source
Escherichia coli
KZM120 ΔacrAB::Tn903 Kanr [66]
S. maltophilia
C357 Urinary isolate [67]
CO47 Clinical Lab collection
CO48 Bronchial aspirate isolate [67]
D388 Urinary isolate [67]
D457 Bronchial aspirate isolate [38]
E301 Urinary isolate [67]
E539 Infected wound isolate [67]
E729 Urinary isolate [67]
E759 Sputum isolate [67]
E824 Blood [67]
E847 Clinical [39]
E923 Sputum isolate [67]
E999 Respiratory secretion isolate [67]
F227 Blood culture isolate [67]
F375 Blood culture isolate [67]
F861 Sputum isolate [67]
G51 Blood culture isolate [67]
e-a21 Sewage (Braunschweig, Germany) [68]
e-a63 Sewage (Braunschweig, Germany) Provided by Gabrielle Berg
e-p5 Rhizosphere of Brassica napus L. (Rostock, Germany) [68]
R551-3 Environmental Provided by Daniel van der Lelie
Plasmids
pGEM-T Cloning vector with polyA, ampr Promega
pBS3.7 pGEM-T with Smqnr of S. maltophilia E759 This work
pBS3.8 pGEM-T with Smqnr of S. maltophilia E923 This work
pBS3.9 pGEM-T with Smqnr of S. maltophilia E999 This work
pBS3.10 pGEM-T with Smqnr of S. maltophilia G51 This work
pBS3.11 pGEM-T with Smqnr of S. maltophilia E539 This work
pBS3.13 pGEM-T with Smqnr of S. maltophilia D388 This work
pBS3.14 pGEM-T with Smqnr of S. maltophilia CO48 This work
pBS3.17 pGEM-T with Smqnr of S. maltophilia C357 This work
pBS3.19 pGEM-T with Smqnr of S. maltophilia F375 This work
pBS3.25 pGEM-T with Smqnr of S. maltophilia E847 This work
pBS3.28 pGEM-T with Smqnr of S. maltophilia CO47 This work
pBS3.30 pGEM-T with Smqnr of S. maltophilia E824 This work
pBS3.D457 pGEM-T with Smqnr of S. maltophilia D457 This work
pBS3.R5 pGEM-T with Smqnr of S. maltophilia R551-3 This work
pBS3.21 pGEM-T with Smqnr of S. maltophilia e-a21 This work
pBS3.63 pGEM-T with Smqnr of S. maltophilia e-a63 This work
like determinants with conserved genetic environments in
the chromosomes of water-borne bacteria, together with
the fact that at least for S. maltophilia the qnr gene is
present in all strains, suggests that their presence in bacte-
rial chromosomes is not the consequence of recent HGT
events due to the selective pressure of quinolones. Thus,
we would expect an ecological role in aquatic environ-
ments for those qnr-like determinants in addition to qui-
nolone resistance.
The study of the S. maltophilia Smqnr gene indicates that
SmQnr confers quinolone resistance when expressed
from a plasmid in a heterologous host, highlighting the
risk of those elements for future development of novel
plasmid-mediated Qnr resistance. Altogether, our data
supports the reliability of using a predictive approach for
analysing antibiotic resistance elements that may poten-
tially disseminate among bacterial populations.Page 10 of 14
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Table 2: MICs (μg/ml) of quinolones for E. coli KZM120 carrying different Smqnr genes from S. maltophilia isolates.
Plasmids Antibiotics
NAL NOR SPA CIP ENX LEV GAR GRP TRV MOX
pGEM-T 1 0.016 0.032 0.002 0.032 0.004 0.002 0.001 0.004 0.004
pBS3.7 1 0.016 0.032 0.004 0.064 0.008 0.016 0.004 0.016 0.008
pBS3.8 1 0.032 0.032 0.008 0.064 0.016 0.032 0.008 0.032 0.016
pBS3.9 1 0.016 0.032 0.004 0.064 0.008 0.016 0.016 0.032 0.016
pBS3.10 1 0.016 0.032 0.004 0.064 0.008 0.008 0.004 0.016 0.016
pBS3.11 1 0.016 0.032 0.004 0.064 0.008 0.004 0.004 0.008 0.008
pBS3.13 1 0.016 0.032 0.004 0.064 0.008 0.008 0.004 0.016 0.016
pBS3.14 1 0.016 0.032 0.004 0.064 0.008 0.008 0.004 0.016 0.016
pBS3.17 1 0.016 0.032 0.004 0.064 0.008 0.016 0.008 0.016 0.016
pBS3.19 1 0.016 0.032 0.004 0.064 0.008 0.008 0.004 0.016 0.008
pBS3.25 1 0.016 0.032 0.004 0.064 0.008 0.064 0.016 0.032 0.032
pBS3.28 1 0.016 0.032 0.004 0.064 0.008 0.004 0.002 0.008 0.008
pBS3.30 1 0.016 0.032 0.004 0.064 0.008 0.004 0.002 0.008 0.008
pBS3.R5 1 0.016 0.032 0.004 0.064 0.008 0.008 0.002 0.016 0.008
pBS3.21 1 0.016 0.032 0.004 0.064 0.008 0.016 0.004 0.016 0.016
pBS3.63 1 0.016 0.032 0.004 0.032 0.008 0.008 0.002 0.008 0.008
NAL; nalidixic acid, NOR; norfloxacin, SPA; sparfloxacin, CIP; ciprofloxacin, ENX; enoxacin, LEV; levofloxacin, GAR; garenoxacin, GRP; 
grepafloxacin, TRV; trovafloxacin, MOX; moxifloxacin.
Estimation of the expression of different SmQnr alleles in E. coliFigure 6
Estimation of the expression of different SmQnr alleles in E. coli. M, molecular mass standards, lane 2, E. coli KZM120 
(ΔacrAB) carrying pGEM-T (negative control), (A) Expression of SmQnr by E. coli strains containing different plasmids that 
encode different SmQnr alleles. The SmQnr protein used for its identification by MS-MALDI-TOF (see Methods) was the allele 
encoded by pBS3.13. (B) To establish the effect of the level of expression of SmQnr on the susceptibility to antibiotics, the 
original clone (1) and two re-transformants (2 and 3) were analysed for each of the plasmids pBS3.8, pBS3.13 and pBS3.25. The 
position of SmQnr is indicated with an arrow.
BMC Microbiology 2008, 8:148 http://www.biomedcentral.com/1471-2180/8/148Table 3: MICs (μg/ml) of quinolones for different colonies of E coli KZM120 containing each of the plasmids pBS3.8, pBS3.25 and 
pBS3.13
Plasmids Antibiotics
NAL NOR SPA CIP ENX LEV GAR GRP TRV MOX
pGEM-T 1 0.016 0.032 0.002 0.032 0.004 0.002 0.001 0.004 0.004
pBS3.8 1 1 0.032 0.032 0.008 0.064 0.016 0.032 0.008 0.032 0.016
pBS3.8 2 1 0.016 0.032 0.004 0.064 0.008 0.016 0.008 0.032 0.016
pBS3.8 3 1 0.016 0.032 0.004 0.064 0.008 0.016 0.008 0.032 0.016
pBS3.13 1 1 0.016 0.032 0.004 0.064 0.008 0.008 0.004 0.016 0.016
pBS3.13 2 1 0.016 0.032 0.004 0.064 0.008 0.002 0.002 0.008 0.008
pBS3.13 3 1 0.016 0.032 0.004 0.064 0.008 0.002 0.002 0.008 0.008
pBS3.25 1 1 0.016 0.032 0.004 0.064 0.008 0.064 0.016 0.032 0.032
pBS3.25 2 1 0.016 0.032 0.004 0.064 0.008 0.008 0.004 0.016 0.008
pBS3.25 3 1 0.016 0.032 0.004 0.064 0.008 0.008 0.004 0.016 0.008
Three colonies were tested for each plasmid.
NAL; nalidixic acid, NOR; norfloxacin, SPA; sparfloxacin, CIP; ciprofloxacin, ENX; enoxacin, LEV; levofloxacin, GAR; garenoxacin, GRP; 
grepafloxacin, TRV; trovafloxacin, MOX; moxifloxacin.
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